Rigel Pharmaceuticals | RIGL - Market Capitalization


Rigel Pharmaceuticals reported $7.02B in Market Capitalization this November of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Agenus USD 128M 21M Mar/2026
Amgen USD 247.94B 20.06B Nov/2026
Anika Therapeutics USD 139M 3M Dec/2025
Arrowhead Research USD 11.5B 2.72B Jun/2026
AstraZeneca USD 213.88B 23.43B Nov/2026
BioMarin Pharmaceutical USD 10.95B 667M Nov/2026
Bristol-Myers Squibb USD 127.46B 9.81B Sep/2026
Celldex Therapeutics USD 1.88B 669M Nov/2026
Daiichi Sankyo JPY 5.22T 356.74B Sep/2026
Eli Lilly USD 1.09T 40.33B Sep/2026
Halozyme Therapeutics USD 15.62B 3.09B Nov/2026
Heron Therapeutics USD 238M 7M Dec/2025
Ionis Pharmaceuticals USD 13.1B 642M Jun/2026
Karyopharm Therapeutics USD 126M 9M Mar/2026
Ligand Pharmaceuticals USD 6.23B 108M Sep/2026
MacroGenics USD 151M 143M Nov/2026
Neurocrine Biosciences USD 14.46B 45M Nov/2026
Pfizer USD 169.88B 6.47B Nov/2026
Ultragenyx Pharmaceutical USD 1.37B 108M Nov/2026
Veracyte USD 4.12B 414M Nov/2026